Should see unis press toward $1 over the next 2 or 3 sessions A...

Should see unis press toward $1 over the next 2 or 3 sessions

A lot of talk around this presentation release on disallowed that will provide holders with a roadmap

There is a lot of unknown detail around the strategy now that Amgen have a relationship with unilife and also regarding position of current unilife management... Shortall being replaced with an Amgen exec would probably send the price to the moon alone... Strong deal, although a lot to be revealed which Imo will determine our next sp level.